Login / Signup
Bruna de Veras
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 6
Top Topics
Public Health
Risk Factors
Cell Free
Big Data
Top Venues
Human vaccines & immunotherapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ru Han
,
Jorge A Gomez
,
Bruna de Veras
,
Thatiana de Jesus Pereira Pinto
,
Adriana Guzmán-Holst
,
Javier Nieto Guevara
,
Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Human vaccines & immunotherapeutics
19 (1) (2023)
Ru Han
,
Jorge A Gomez
,
Bruna de Veras
,
Thatiana de Jesus Pereira Pinto
,
Adriana Guzmán-Holst
,
Javier Nieto Guevara
,
Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Human vaccines & immunotherapeutics
19 (1) (2023)
Ru Han
,
Jorge A Gomez
,
Bruna de Veras
,
Thatiana de Jesus Pereira Pinto
,
Adriana Guzmán-Holst
,
Javier Nieto Guevara
,
Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Human vaccines & immunotherapeutics
(2023)
Ru Han
,
Jorge A Gomez
,
Bruna de Veras
,
Thatiana de Jesus Pereira Pinto
,
Adriana Guzmán-Holst
,
Javier Nieto Guevara
,
Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Human vaccines & immunotherapeutics
19 (1) (2023)
Ru Han
,
Jorge A Gomez
,
Bruna de Veras
,
Thatiana de Jesus Pereira Pinto
,
Adriana Guzmán-Holst
,
Javier Nieto Guevara
,
Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Human vaccines & immunotherapeutics
19 (1) (2023)
Ru Han
,
Jorge A Gomez
,
Bruna de Veras
,
Thatiana de Jesus Pereira Pinto
,
Adriana Guzmán-Holst
,
Javier Nieto Guevara
,
Désirée A M van Oorschot
How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Human vaccines & immunotherapeutics
19 (1) (2023)